USPTO serial 79139582
VARITHENA
Reviewed by CopyMark Law Group
Reg. 4638965Status 404
- Filing date
- Status date
- Registration date
- Nov 18, 2014
- Examiner
- IM, JEAN H
- Law office
- POST REGISTRATION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with VARITHENA?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Chemicals for use in the manufacture of pharmaceuticals for the treatment of angiologic disorders, particularly varicose veins; chemicals for use in the manufacture of injectable foams | SECTION 71 - CANCELLED | — |
| 005 | Pharmaceutical preparations in the form of foams for use in sclerotherapy treatment of veins; pharmaceutical preparations in the form of foams for use in producing foams for use in sclerotherapy treatment of veins; pharmaceutical preparations in the form of foams or for use in preparing foams, for sclerotherapy, phlebology, angiology and proctology, for treatment of oesophageal varices, hydroceles, in sterilisation treatment or for treatment of varicose veins, or arterio-venous malformations | SECTION 71 - CANCELLED | — |
| 010 | Needles for medical use, namely, cannula needles; medical tubing for sclerotherapy; medical tubing for the treatment of varicose veins, venous malformations, arterio-venous malformations, oesophageal varices and hydroceles * none of the aforementioned goods being supportive bandages or compression bandages *; surgical and medical apparatus for producing and administering foams for the treatment of varicose veins, venous malformations, arterio-venous malformations, oesophageal varices and hydroceles * none of the aforementioned goods being supportive bandages or compression bandages *; surgical and medical apparatus for producing and administering sclerosing foams for the treatment of varicose veins, venous malformations, arterio-venous malformations, oesophageal varices and hydroceles * none of the aforementioned goods being supportive bandages or compression bandages *; surgical or medical apparatus for producing and administering foams for use in sclerotherapy, phlebology, angiology or proctology; syringes for producing and administering foams for use in sclerotherapy, phlebology, angiology or proctology; surgical and medical apparatus for administering and producing foams for use in sterilisation treatment; surgical and medical apparatus for use in treatment of varicose veins, arterio-venous malformations, oesophageal varices or hydroceles * none of the aforementioned goods being supportive bandages or compression bandages *; syringes for use in treatment of varicose veins, arterio-venous malformations, oesophageal varices or hydroceles * none of the aforementioned goods being supportive bandages or compression bandages *; devices for assessing the physical characteristics of such foams; medical devices for intravenous administration of sclerosing foam for the treatment of varicose veins, venous malformations, arterio-venous malformations, oesophageal varices and hydroceles * none of the aforementioned goods being supportive bandages or compression bandages *; medical devices for monitoring the position and effect of foam in the human body; medical diagnostic apparatus for diagnosing all the above medical conditions | SECTION 71 - CANCELLED | — |
| 042 | Scientific research services related to sclerotherapy of veins, namely scientific research relating to provision of medical treatment in the fields of phlebology, proctology and angiology | SECTION 71 - CANCELLED | — |
| 044 | Medical services for diagnosis in the fields of sclerotherapy, phlebology, angiology and proctology and, in particular, in relation to varicose veins, arterio-venous malformations, oesophageal varices and sterilization treatment; medical evaluation of diseases or disorders in the fields of sclerotherapy, phlebology, angiology and proctology, varicose veins, arterio-venous malformations, oesophageal varices and sterilization treatment; medical treatment of diseases or disorders in the fields of sclerotherapy, phlebology, angiology and proctology, varicose veins, arterio-venous malformations, oesophageal varices and sterilization treatment; medical services provided to post-treatment and homecare patients in the fields of sclerotherapy, phlebology, angiology, varicose veins, arterio-venous malformations, oesophageal varices and sterilization treatment; providing outpatient medical services regarding the administering of medications and therapy in the fields of sclerotherapy, phlebology, angiology, varicose veins, arterio-venous malformations, oesophageal varices and sterilization treatment | SECTION 71 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Provensis Limited
- Other trademarks owned by Provensis Limited
- Other trademarks owned by Provensis Limited
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 010
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named VARITHENA
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Nov 20, 2023 | DENC | NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED | — |
| Nov 20, 2023 | DETH | DEATH OF INTERNATIONAL REGISTRATION | — |
| Jul 17, 2022 | INNT | TOTAL INVALIDATION PROCESSED BY THE IB | — |
| Jun 3, 2022 | INTS | TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB | — |
| Jun 3, 2022 | INPC | INVALIDATION PROCESSED | — |
| Feb 4, 2022 | INTR | TOTAL INVALIDATION OF REG EXT PROTECTION CREATED | — |
| Jan 8, 2022 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Jun 4, 2021 | C71T | CANCELLED SECTION 71 | — |
| Oct 13, 2017 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Feb 17, 2016 | INNA | INVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE | — |
| Dec 22, 2015 | CORR | CORRECTION FROM IB ENTERED - NO REVIEW REQUIRED | — |
| Dec 4, 2015 | INPR | PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED | — |
| Nov 7, 2015 | CRCV | CORRECTION TRANSACTION RECEIVED FROM IB | — |
| Jul 11, 2015 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Jun 23, 2015 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Jun 23, 2015 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Apr 4, 2015 | COC. | CORRECTION UNDER SECTION 7 - PROCESSED | — |
| Apr 4, 2015 | PLGL | ASSIGNED TO PARALEGAL | — |
| Apr 2, 2015 | LIME | LIMITATION FROM THE IB EXAMINED AND ENTERED | — |
| Mar 27, 2015 | LIMG | LIMITATION OF GOODS RECEIVED FROM IB | — |
| Feb 18, 2015 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Nov 18, 2014 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Sep 2, 2014 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Aug 29, 2014 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Aug 13, 2014 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Aug 13, 2014 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Aug 13, 2014 | NPUB | NOTICE OF PUBLICATION | — |
| Jul 25, 2014 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Jul 24, 2014 | ALIE | ASSIGNED TO LIE | — |
| Jul 11, 2014 | CNEA | EXAMINERS AMENDMENT MAILED | — |
| Jul 10, 2014 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jul 10, 2014 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Jul 10, 2014 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Jun 18, 2014 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jun 18, 2014 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jun 18, 2014 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jan 6, 2014 | RFNT | REFUSAL PROCESSED BY IB | — |
| Dec 20, 2013 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Dec 19, 2013 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Dec 19, 2013 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Dec 19, 2013 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Dec 18, 2013 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 16, 2013 | DOCK | ASSIGNED TO EXAMINER | — |
| Dec 16, 2013 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Dec 13, 2013 | LIMI | LIMITATION FROM ORIGINAL APPLICATION ENTERED | — |
| Dec 12, 2013 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |